Target intelligence / Profile preview

RNA, U6 small nuclear 23, pseudogene (RNU6-23P)

Target
RNU6-23P
Molecular classification
Other, Pseudogene, Small nuclear RNA pseudogene
01

Overview

RNU6-23P is a processed pseudogene classified as a non-coding RNA locus related to the U6 small nuclear RNA gene family[2]. The U6 small nuclear RNA (snRNA) itself is a critical RNA component of the spliceosome, orchestrating pre-mRNA splicing by catalyzing the splicing reaction within the nucleus[1]. However, RNU6-23P does not generate a functional U6 snRNA or protein; it is a relic of genomic duplication or retrotransposition without evidence of functional transcription or therapeutic relevance[2]. Pseudogenes such as RNU6-23P may arise from retrotranspositional events driven by elements like LINEs (long interspersed nuclear elements), resulting in genomic copies of snRNA genes that are not expressed or functional[2]. These pseudogenes typically have no demonstrated biological function, disease association, drug interactions, or utility as therapeutic targets. Notes on correctness: - RNU6-23P is not a protein, enzyme, receptor, transporter, or other conventional drug target—rather, it is a genomic pseudogene. - There is no evidence linking this pseudogene to disease, drug targeting, or biomarker potential. In summary: RNU6-23P is a non-functional pseudogene and not a biologically active or therapeutically relevant target[2][3].

Other names
RNU6-23RNU6-23P

Beyond the preview

Go deeper on RNA, U6 small nuclear 23, pseudogene (RNU6-23P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 23, pseudogene (RNU6-23P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call